Pacific Biosciences of California, Inc. (PACB)
1.61
-0.07
(-4.17%)
USD |
NASDAQ |
Feb 20, 16:00
1.615
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California SG&A Expense (Quarterly) : 34.05M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 26.74M |
| Twist Bioscience Corp. | 69.74M |
| Boston Scientific Corp. | 1.834B |
| Intellia Therapeutics, Inc. | 30.51M |
| Enovis Corp. | 263.62M |